emerge semaglutide GLP-1 medications are dominating the conversation right now, but most of that conversation has focused on just one thing: weight loss. A different clinical question is starting to emerge…Could GLP-1 therapies offer Semaglutide for Weight Loss |

Neuland announces a $30mn investment to expand its global Peptide production capabilities

But the core molecule is now public property in most of the world, and the $26 billion business built on it will look very different by 2033

Stopping or interrupting GLP-1 receptor agonists “erode and could ultimately reverse&rdquo

New research presented at the Endocrine Society's ENDO 2026 meeting is generating interest among clinicians who manage obesity, testosterone deficiency, and male reproductive health

Call an Ozempic lawsuit lawyer if you or someone you care about has suffered injuries or death after taking this dangerous drug

Thursday, June 25, 2026 | 4:005:00 PM EST | Virtual (Zoom) Hosted by Tricia Ryan, BA, BSc, MBA Ryan, Director of Membership Development, Baking Association of Canada Featuring expert speakers: Derrick Lichti, Founding Engineer & Chief Data Officer, RxFood Corporation.com Reid McEachran, International Marketing Manager, Ardent Mills Seats are limited